Author: IFI CLAIMS

The following news articles are in our database from this author…

July 1st 2021, 7:00 PM Leading patent data platform IFI CLAIMS joins Digital Science
December 15th 2021, 10:34 PM Fall 2021 Newsletter
January 9th 2022, 7:00 PM IFI CLAIMS Announces 2021 Top Global Patent Holders
January 11th 2022, 7:00 PM Despite Pandemic, Patent Activity Remains Strong
February 20th 2022, 7:00 PM Winter Newsletter 2022
March 15th 2022, 8:00 PM IFI Insights: Do patent applications of electric vehicle startups predict the road ahead
March 22nd 2022, 8:00 PM The companies leading the race for new electric vehicle technology
April 27th 2022, 7:00 PM Spring Newsletter 2022
July 20th 2022, 9:00 AM Which companies could become Maestros of the Metaverse?
August 2nd 2022, 2:00 AM Summer Newsletter 2022
December 2nd 2022, 12:23 PM Fall Newsletter 2022
January 10th 2023, 5:00 AM Samsung Leads in U.S. Patents as Overall Grants Hit Four-Year Low
January 25th 2023, 5:00 AM IFI Insights: How Renewable Are U.S. Energy Patents?
January 25th 2023, 5:00 AM 'Green' energy patents more focused on 'clean' conventional energy instead of renewables
January 4th 2024, 4:36 PM Samsung Leads Again in U.S. Patents while Qualcomm Leaps into Second Place
January 6th 2024, 2:59 PM IFI Insights: Opening the Patent Picture on Generative AI
February 6th 2024, 3:56 PM IBM leads Google and Microsoft as race to next generation AI heats up
March 26th 2024, 7:30 AM IFI CLAIMS Technology Spotlight: AI and the Real Estate Sector
March 27th 2024, 8:55 AM IFI Spring Newsletter 2024
June 20th 2024, 4:00 AM The IFI Deal: Walmart Goes Shopping For Vizio
July 9th 2024, 4:33 PM IFI Summer Newsletter 2024
September 23rd 2024, 5:00 AM IFI CLAIMS Technology Spotlight: Semiconductors
November 12th 2024, 7:00 AM IFI CLAIMS Technology Spotlight: Cybersecurity
November 20th 2024, 6:00 AM IFI Fall Newsletter 2024
January 8th 2025, 1:30 PM Samsung Takes Top Spot in U.S. Patents for Third Year Running
February 12th 2025, 6:00 AM IFI Winter Newsletter 2025
March 4th 2025, 5:00 AM IFI Insights: Anti-Obesity Drugs